GlobalData on MSN1d
PhaseV and Alimentiv to support execution of adaptive clinical trials for GI
The partnership will integrate PhaseV's adaptive clinical trial technology with Alimentiv's comprehensive GI CRO services.
PhaseV and Alimentiv Partner on Machine Learning-Based Solution to Tackle Challenges in GI Clinical Trials
PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today it has entered a ...
FierceBiotech2d
GI-focused CRO Alimentiv ups trial tech with PhaseV’s adaptive machine learning software
Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...
Hosted on MSN11mon
PhaseV partners with iOMEDICO to improve Phase III trial outcomes
Israel-based PhaseV has partnered with clinical research organisation iOMEDICO to introduce a new machine learning (ML) powered solution aimed at optimising and de-risking Phase III oncology ...
Morningstar20d
PhaseV Advances Machine Learning-Driven Lupus Research in New Toronto Collaboration
Collaboration Leveraging University Health Network's Expertise to Evaluate PhaseV's Machine Learning (ML) Platform to Identify Causes of Lupus Progression and Improve Drug Development SLE is a ...
GlobalData on MSN3mon
Var Energi and Kistos sanction $690m investment for Balder Phase V
Var Energi and Kistos Energy Norway have made the final investment decision (FID) for the Balder Phase V project in the ...